Natalya Danchenko, Ph.D.
Affiliations: | 2005 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Public Health, Medicine and SurgeryGoogle:
"Natalya Danchenko"Cross-listing: PHTree
Parents
Sign in to add mentor| Kim Sutton-Tyrrell | grad student | 2005 | University of Pittsburgh | |
| (Enhancing diagnosis and management of systemic lupus erythematosus.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Atsou K, Ereshefsky L, Brignone M, et al. (2020) Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant. Expert Review of Pharmacoeconomics & Outcomes Research |
| Atsou K, Ereshefsky L, Brignone M, et al. (2020) Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant. Expert Review of Pharmacoeconomics & Outcomes Research |
| Lam RW, Lamy FX, Danchenko N, et al. (2018) Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder. Neuropsychiatric Disease and Treatment. 14: 2861-2877 |
| Thase ME, Danchenko N, Brignone M, et al. (2017) Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology |
| Young AH, Evitt L, Brignone M, et al. (2017) Cost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom. Journal of Affective Disorders. 218: 291-298 |
| Florea I, Loft H, Danchenko N, et al. (2017) The effect of vortioxetine on overall patient functioning in patients with major depressive disorder. Brain and Behavior. 7: e00622 |
| François C, Nielsen R, Danchenko N, et al. (2017) The impact of antidepressant treatments on family functioning in adults with major depressive disorder: a post hoc comparison of vortioxetine and agomelatine. Current Medical Research and Opinion. 1-24 |
| Soini E, Hallinen T, Brignone M, et al. (2016) Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland. Expert Review of Pharmacoeconomics & Outcomes Research |
| Williams V, François C, Danchenko N, et al. (2016) Psychometric validation of the depression and family functioning scale. Current Medical Research and Opinion. 1-12 |
| Evitt L, Danchenko N, Atsou K, et al. (2016) Cost-Effectiveness Evaluation of Vortioxetine in Major Depressive Episode in the UK Setting Value in Health. 19 |